C A Papadimitriou, M A Dimopoulos, V Kouvelis, E Kostis, V Kapsimali, D Contoyannis, A Anagnostopoulos, C Papadimitris, C Kiamouris, D Gika, J Nanas, P Athanassiades, S Stamatelopoulos
High-dose chemotherapy with autologous peripheral blood progenitor cell (PBPC) support has become a widely used treatment strategy. In order to simplify the procedure, a single very large-volume leukapheresis programme combined with short-term refrigerated storage of the PBPC was developed. Seventy-two patients suffering from various relatively chemosensitive malignancies received high-dose chemotherapy, consisting of agents with short in vivo half-lives and 24 to 48 hours later, the refrigerated PBPC were reinfused...
2000: Journal of Clinical Apheresis